Professor Julian Sampson
Projects as PI
1 of 5
- A randomised, double blind, placebo-controlled study of RAD001 (Everolimus) in the treatment of neurocognitive problems in tuberous sclerosis (01/09/2011 - 30/09/2018)
- A single site, randomised, double blind, placebo-controlled clinical trial of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (01/09/2011 - 30/06/2020)
- Better DNA diagnostics for tuberous sclerosis (01/06/2007 - 31/05/2010)
- Cancer Genetics Biomedical Research Unit (31/03/2011 - 31/05/2015)
- Clinical research fellow in genomic medicine (29/04/2019 - 30/06/2024)
Projects as Co-Investigator
5 of 5
- Wales Cancer Bank (01/04/2003 - 31/03/2015)
- Wales Cancer Research Centre (01/04/2015 - 31/03/2018)
- Wales Cancer Research Centre (01/04/2018 - 31/03/2021)
